Are novel drugs more risky for patients than less novel drugs?
Year of publication: |
2004
|
---|---|
Authors: | Olson, Mary K. |
Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 23.2004, 6, p. 1135-1158
|
Subject: | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | USA | United States |
-
Bargaining and international reference pricing in the pharmaceutical industry
Dubois, Pierre, (2022)
-
(1984)
-
(1985)
- More ...
-
Olson, Mary K., (2020)
-
Pharmaceutical expenditure and regulatory policy in the NHS
Olson, Mary K., (1992)
-
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K., (1993)
- More ...